Expertise in
18
conditions

Jing H. Shi

221 West Yanan Road, 
Shanghai, CN 
Expertise in
18
conditions
221 West Yanan Road, 
Shanghai, CN 
OverviewLocationsClinical Research

Overview

Jing Shi practices in Shanghai, China. Ms. Shi is highly rated in 18 conditions, according to our data. Her top areas of expertise are Vascular Dementia, Behcet Disease, Adenomyosis, Intrauterine Device Insertion, and Endoscopy.

Her clinical research consists of co-authoring 742 peer reviewed articles and participating in 3 clinical trials. MediFind looks at clinical research from the past 15 years.

Gender
Female

Locations

221 West Yanan Road, Shanghai, 200040, China
Other Locations
Baoshan Branch, Shanghai, China
No. 5, Zhongguancun South Street, Beijing, 100081, China
Guizhou Provincial Engineering Technology Research Center For Chemical Drug R&D, Guiyang, 550014, China
1678 Dongfang Road, Dongfang, 200127, China
600 Tianhe Road, Guangzhou, 510630, China
No.157 Health Road, Harbin, 150000, China
No. 5 Zhongguancun South Street, Haidian, 100081, China
28 Fuxing Road, Haidian, 100853, China
172 Tan Xi Road, Xiangyang, China
180 Fenglin Road, Shanghai, 200032, China
General Hospital Of Daqing Oil Field, Daqing, China

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

3 Clinical Trials

The Safety and Efficacy of 1612 Capsules in Treatment of aMnestic Mild Cognitive Impairment: a 52-week, Double Blind,Randomized, Parallel,Placebo Controlled Trial.
The Safety and Efficacy of 1612 Capsules in Treatment of aMnestic Mild Cognitive Impairment: a 52-week, Double Blind,Randomized, Parallel,Placebo Controlled Trial.
Enrollment Status: Withdrawn
Publish Date: March 04, 2021
Intervention Type: Drug
Study Phase: Phase 4
Efficacy and Safety of Twice Daily TMBCZG in Mild to Moderate Vascular Dementia: Randomized, Double Blind, Parallel Group, Placebo Controlled, Multicenter Trial
Efficacy and Safety of Twice Daily TMBCZG in Mild to Moderate Vascular Dementia: Randomized, Double Blind, Parallel Group, Placebo Controlled, Multicenter Trial
Enrollment Status: Completed
Publish Date: March 02, 2021
Intervention Type: Drug, Other
Study Phase: Phase 2
The Efficacy and Safety of Qinggongshoutao Bolus for aMnestic Mild Cognitive Impairment: A 52- Week Randomized, Double-blind, Controlled,Three Arms, Multi-center Study
The Efficacy and Safety of Qinggongshoutao Bolus for aMnestic Mild Cognitive Impairment: A 52- Week Randomized, Double-blind, Controlled,Three Arms, Multi-center Study
Enrollment Status: Completed
Publish Date: October 23, 2018
Intervention Type: Drug
Study Phase: Phase 4
View 2 Less Clinical Trials

742 Total Publications

SPARC: A Multipayload ADC Architecture for Programmable Drug Combinations.
SPARC: A Multipayload ADC Architecture for Programmable Drug Combinations.
Journal: Bioconjugate chemistry
Published: September 17, 2025

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Ms. Shi's expertise for a condition
ConditionClose
    View All 16 Advanced Conditions
    View All 174 Experienced Conditions
    Want to save this expert for later?
    Sign Up
    Not sure about your diagnosis?
    Check Your Symptoms
     
     
     
     
    Learn about our expert tiers
    Learn More
    Are you the provider on this profile?
    Claim Profile